Inhibition of the VEGF pathway in cancer is thought to not only reduce the total number of vessels to support tumor growth, but also improve the function of vessels within the tumor, thereby more effectively delivering other anti-cancer therapeutics [10]. The gene discussed is VEGFA; the disease is neoplasm.